• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有表皮生长因子受体(EGFR)突变的肺腺鳞癌异时性孤立性对侧肺转移

Metachronous Isolated Contralateral Lung Metastasis from Pulmonary Adenosquamous Carcinoma with EGFR Mutation.

作者信息

Kawai Hitomi, Iguchi Kesato, Takayashiki Norio, Okauchi Shinichiro, Satoh Hiroaki

机构信息

Division of Pathology, Mito Medical Center, University of Tsukuba-Mito Medical Center, Mito, Ibaraki, Japan.

Division of Surgery, Mito Medical Center, University of Tsukuba-Mito Medical Center, Mito, Ibaraki, Japan.

出版信息

Acta Medica (Hradec Kralove). 2020;63(3):141-144. doi: 10.14712/18059694.2020.33.

DOI:10.14712/18059694.2020.33
PMID:33002403
Abstract

Lung metastasis and metachronous double primary lung cancer are both common and often present diagnostic challenges. We present a case of metachronous isolated contralateral lung metastasis from pulmonary adenosquamous carcinoma with EGFR mutation. A 75-yearold woman presented with left lung nodule on a routine follow-up chest radiograph. She had had surgery for pulmonary adenocarcinoma with EGFR Ex21 L858R mutation 6 years ago. She underwent surgical resection, and histologic findings revealed adenosquamous carcinoma with the same EGFR mutation. Re-assessment of the resected specimen of the primary tumor resected 6 years ago revealed the morphologically similarity to the left lung tumor. Based on morphological and genetic identity, final diagnosis was adenosquamous cell carcinoma and metachronous isolated contralateral lung metastasis. The diagnosis of metachronous isolated metastasis is difficult but important for appropriate management and prediction of prognosis. A careful pathological examination and evaluation of genetic abnormality are needed to make the correct diagnosis.

摘要

肺转移和异时性双原发性肺癌都很常见,且常常带来诊断挑战。我们报告一例伴有EGFR突变的肺腺鳞癌异时性孤立性对侧肺转移病例。一名75岁女性在常规胸部X线随访检查时发现左肺结节。她6年前曾因EGFR Ex21 L858R突变的肺腺癌接受手术。她接受了手术切除,组织学检查结果显示为具有相同EGFR突变的腺鳞癌。对6年前切除的原发性肿瘤切除标本进行重新评估,发现其在形态学上与左肺肿瘤相似。基于形态学和基因一致性,最终诊断为腺鳞癌并异时性孤立性对侧肺转移。异时性孤立性转移的诊断困难,但对于恰当的治疗管理和预后预测很重要。需要进行仔细的病理检查和基因异常评估以做出正确诊断。

相似文献

1
Metachronous Isolated Contralateral Lung Metastasis from Pulmonary Adenosquamous Carcinoma with EGFR Mutation.伴有表皮生长因子受体(EGFR)突变的肺腺鳞癌异时性孤立性对侧肺转移
Acta Medica (Hradec Kralove). 2020;63(3):141-144. doi: 10.14712/18059694.2020.33.
2
Clinical Significance of Detecting Somatic Gene Mutations in Surgically Resected Adenosquamous Cell Carcinoma of the Lung in Japanese Patients.日本患者手术切除的肺腺鳞癌中检测体细胞基因突变的临床意义
Ann Surg Oncol. 2015 Aug;22(8):2593-8. doi: 10.1245/s10434-014-4218-0. Epub 2014 Nov 6.
3
[The clinical and pathological features, biomarker characteristics and prognosis analysis of lung adenosquamous carcinoma].[肺腺鳞癌的临床病理特征、生物标志物特点及预后分析]
Zhonghua Zhong Liu Za Zhi. 2019 Jan 23;41(1):50-55. doi: 10.3760/cma.j.issn.0253-3766.2019.01.009.
4
[The efficacy and influence factors analysis of EGFR TKIs on patients with lung adenosquamous carcinoma].[表皮生长因子受体酪氨酸激酶抑制剂对肺腺鳞癌患者的疗效及影响因素分析]
Zhonghua Zhong Liu Za Zhi. 2018 Oct 23;40(10):776-781. doi: 10.3760/cma.j.issn.0253-3766.2018.10.010.
5
Clinicopathological characteristics and prognosis of patients with adenosquamous lung carcinoma.肺腺鳞癌患者的临床病理特征及预后
J Huazhong Univ Sci Technolog Med Sci. 2015 Jun;35(3):350-355. doi: 10.1007/s11596-015-1436-z. Epub 2015 Jun 14.
6
Complete pathologic response to neoadjuvant icotinib in stage IIIA EGFR-mutant lung adenosquamous carcinoma: A case report.IIIA期EGFR突变型肺腺鳞癌对新辅助埃克替尼的完全病理缓解:一例报告
Medicine (Baltimore). 2024 Jan 26;103(4):e36214. doi: 10.1097/MD.0000000000036214.
7
[Erlotinib plus Bevacizumab Therapy for Postoperative Recurrence of Adenosquamous Cell Carcinoma Harboring EGFR Mutation-A Case Report].[厄洛替尼联合贝伐单抗治疗携带EGFR突变的腺鳞癌术后复发——一例报告]
Gan To Kagaku Ryoho. 2021 Jun;48(6):841-843.
8
Prevalence and Clinical Profile of EGFR Mutation In Non- Small-Cell Lung Carcinoma Patients in Southwest China.中国西南地区非小细胞肺癌患者表皮生长因子受体突变的患病率及临床特征
Asian Pac J Cancer Prev. 2016;17(3):965-71. doi: 10.7314/apjcp.2016.17.3.965.
9
The long-term survival of a patient with adenosquamous lung carcinoma harboring EGFR-activating mutations who was treated with gefitinib.一名患有伴有EGFR激活突变的腺鳞癌肺癌患者接受吉非替尼治疗后的长期生存情况。
Intern Med. 2012;51(19):2771-4. doi: 10.2169/internalmedicine.51.7428. Epub 2012 Oct 1.
10
Epidermal Growth Factor Receptor Mutation as a Risk Factor for Recurrence in Lung Adenocarcinoma.表皮生长因子受体突变作为肺腺癌复发的危险因素。
Ann Thorac Surg. 2018 Jun;105(6):1648-1654. doi: 10.1016/j.athoracsur.2018.01.052. Epub 2018 Feb 24.

引用本文的文献

1
Multiple primary lung cancer comprised of adenocarcinoma and adenoid cystic carcinoma: a case report.由腺癌和腺样囊性癌组成的多原发性肺癌:一例报告
Transl Cancer Res. 2022 Mar;11(3):591-596. doi: 10.21037/tcr-22-166.